Authors: Horiuchi, H Saito, N Kinoshita, T Wakabayashi, S Tsutsumimoto, T Takaoka, K

Citation: H. Horiuchi et al., Enhancement of bone morphogenetic protein-2-induced new bone formation in mice by the phosphodiesterase inhibitor pentoxifylline, BONE, 28(3), 2001, pp. 290-294

Authors: Yoshimura, Y Nomura, S Kawasaki, S Tsutsumimoto, T Shimizu, T Takaoka, K

Citation: Y. Yoshimura et al., Colocalization of noggin and bone morphogenetic protein-4 during fracture healing, J BONE MIN, 16(5), 2001, pp. 876-884

Authors: Kinoshita, T Kobayashi, S Ebara, S Yoshimura, Y Horiuchi, H Tsutsumimoto, T Wakabayashi, S Takaoka, K

Citation: T. Kinoshita et al., Phosphodiesterase inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice, BONE, 27(6), 2000, pp. 811-817

Authors: Kobayashi, S Shimizu, T Mehdi, R Nawata, M Kojima, S Tsutsumimoto, T Iorio, R Takaoka, K

Citation: S. Kobayashi et al., Advantages of concurrent use of anabolic and antiresorptive agents over single use of these agents in increasing trabecular bone volume, connectivity, and biomechanical competence of rat vertebrae, BONE, 25(6), 1999, pp. 703-712

Authors: Tsutsumimoto, T Kawasaki, S Ebara, S Takaoka, K

Citation: T. Tsutsumimoto et al., TNF-alpha and IL-1 beta suppress N-cadherin expression in MC3T3-E1 cells, J BONE MIN, 14(10), 1999, pp. 1751-1760